KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Accumulated Expenses (2016 - 2025)

Medpace Holdings' Accumulated Expenses history spans 11 years, with the latest figure at $408.4 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 32.67% year-over-year to $408.4 million; the TTM value through Dec 2025 reached $408.4 million, up 32.67%, while the annual FY2025 figure was $408.4 million, 32.67% up from the prior year.
  • Accumulated Expenses reached $408.4 million in Q4 2025 per MEDP's latest filing, up from $368.7 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $408.4 million in Q4 2025 to a low of $29.0 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $217.2 million, with a median of $248.4 million recorded in 2023.
  • Peak YoY movement for Accumulated Expenses: crashed 72.89% in 2021, then soared 350.51% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $159.3 million in 2021, then surged by 31.92% to $210.1 million in 2022, then surged by 39.42% to $293.0 million in 2023, then grew by 5.07% to $307.8 million in 2024, then skyrocketed by 32.67% to $408.4 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Accumulated Expenses are $408.4 million (Q4 2025), $368.7 million (Q3 2025), and $323.5 million (Q2 2025).